New Stock News | Huaheng Biology (688639.SH) Submits a Filing to the Hong Kong Stock Exchange

According to the Wise Wealth APP, it was disclosed by the Hong Kong Stock Exchange on April 30, 2026 that Anhui Huaheng Biotechnology Co., Ltd. (referred to as: Hua Heng Biotechnology (688639.SH)) has submitted an application for listing to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor. The prospectus shows that Hua Heng Biotechnology is the world's first enterprise to industrialize the anaerobic fermentation of series of amino acids (including L-proline and L-valine), with the company's market share of L-proline and L-valine ranking first in the world based on revenue in 2024.